Page 5 - Demo

Cosmeticmanufacturingequipment%ud654%uc7a5%ud488 %uc81c%uc870%uc124%ube44- %ub300%ub7c9%uc0dd%uc0b0 %uc124%ube44 %ubc0f %uc2dc%uc2a4%ud15c %uad6c%ucd95 %u00b7 300L, 500L, 1000L %ud638%ubaa8 %uc720%ud654%ub7ad%ud06c %ubc0f 2000L %uc544%uc9c0%ubd84%uc0b0%ud06c %ub4f1 %u00b7 %ub9c8%uc2a4%ud06c%ud329 %ucda9%uc9c4%uae30, %ud06c%ub9bc %ucda9%uc9c4%uae30, %uc815%ub7c9 %ucda9%uc804%uae30, %ub300%uc6a9%ub7c9 %ucda9%uc804%uae30, %uc720%uc561%uc0c1 %uc790%ub3d9 %uacf5%uae09%uae30 %ub4f1- %ub2e4%ud488%uc885%uc18c%ub7c9%uc0dd%uc0b0%uc744 %uc704%ud55c %uc0dd%uc0b0 %uc124%ube44 %uad6c%ucd95 %u00b7 30L, 50L, 100L %ud638%ubaa8 %uc720%ud654%ub7ad%ud06c %u00b7 %ub2e8%ubc1c %ucda9%uc9c4%uae30, %uc218%ub3d9 %ucea1%ud551%uae30Corporate supportstatus%uae30%uc5c5%uc9c0%uc6d0 %ud604%ud669- %uae00%ub85c%ubc8c %uc218%uc900%uc758 %ud488%uc9c8 %uacbd%uc7c1%ub825 %ud655%ubcf4%ub97c %uc704%ud55c %uad6d%ub0b4%uc678 %uc778%uc99d%uc9c0%uc6d0- %uad6d%ub0b4%uc678 %ud310%ub85c %uac1c%ucc99%uc744 %uc704%ud55c %uc804%uc2dc%ud68c %ucc38%uac00%uc9c0%uc6d0- %uc5f0%uad6c%uc7a5%ube44 %uc9c0%uc6d0%uc744 %ud1b5%ud55c %uc9c0%uc5ed%uae30%uc5c5%uc758 %uae30%uc220%uacbd%uc7c1%ub825 %uac15%ud654 %uc9c0%uc6d0%uae00%ub85c%ubc8c %ucf54%uc2a4%uba54%ud2f1 %ube44%uc988%ub2c8%uc2a4%uc13c%ud130Global Cosmetic Business CenterUtilities and CGMPfacilities%uc720%ud2f8%ub9ac%ud2f0 %ubc0f CGMP %uc2dc%uc124- %uc2dd%uc57d%ucc98 CGMP %ubc0f IS022716%uc744 %uc704%ud55c %uc124%ube44 %ubc0f %uc2dc%uc124 %uc6b4%uc601- %uc601%ub0a8%uad8c %ucd5c%ub300%uc758 CGMP/1S022716 %uc2dc%uc2a4%ud15c %uad6c%ucd95Quality facilitystatus%ud488%uc9c8 %uc124%ube44 %ud604%ud669- %ud654%uc7a5%ud488 %uc548%uc804 %uad00%ub9ac%uae30%uc900%uc744 %uc704%ud55c ICP-OES, ICP-MS, %uc218%uc740%ubd84%uc11d%uae30 %ub4f1 %uc815%ubc00%ubd84%uc11d%uc7a5%ube44 %uad6c%ucd95 %u00b7 10%uac1c %ud56d%ubaa9%uc5d0 %ub300%ud55c %uac80%uc0ac %uac00%ub2a5- %ubbf8%uc0dd%ubb3c %ubc30%uc591 %ubc0f %ubd84%uc11d %ub2a5%ub825%uc744 %uac16%ucd94%uc5b4 %uc0dd%uade0%uc218 %ubc30%uc591%uce21%uc815 %ubc0f %ubcd1%uc6d0%uade0 %ud655%uc778, %ubc29%ubd80%ub825 %u00b7 %ud6a8%ub2a5%uc2e4%ud5d8 %ub4f1 %uc2e4%ud5d8%uac00%ub2a5%ud558%uc5ec %uc720%ub7fd %ub4f1%uc758 %uad6d%uc81c %uaddc%uaca9%uc5d0 %ud544%uc694%ud55c %ud488%uc9c8 %uc2dc%ud5d8 %ub300%uc751 %uac00%ub2a5Research facilitystatus%uc5f0%uad6c%uc2dc%uc124 %ud604%ud669- %uae30%ucd08%uc81c%ud615 %uc5f0%uad6c%uc2e4%uc744 %ud1b5%ud55c %ud2b9%uc218%uc81c%ud615 %uac1c%ubc1c %ubc0f %uc81c%ud488%ud654 %uc2e4%ud604- %ucc9c%uc5f0%ubb3c%uc758 in vivo, in vitro, %uac04%uc774%uc784%uc0c1%ud3c9%uac00 %uc5f0%uad6c- %ud654%uc7a5%ud488%uc758 %ud53c%ubd80%uc801%uc6a9 %ud6a8%ub2a5 %ud6a8%uacfc %ubd84%uc11d %uc7a5%ube44 %ubcf4%uc720%ub97c %ud1b5%ud55c %uc81c%ud488%uc758 %uc2e0%uccb4%uc801%uc6a9 %ubc0f %ud6a8%ub2a5%uac80%uc99d %uc2dc%ud5d8%uacbd%uc0c1%ubd81%ub3c4 %uacbd%uc0b0%uc2dc %uc0bc%uc131%ud604%ub85c 738(%uae00%ub85c%ubc8c %ucf54%uc2a4%uba54%ud2f1 %ube44%uc988%ub2c8%uc2a4%uc13c%ud130) | T. 053-812-0276 | E. cos@gitc.or.kr | H. https//www.gcbc.or.kr